AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Baillie Gifford's Strategic Moves: Shopify Inc. Sees Significant Reduction
ByAinvest
Saturday, Aug 9, 2025 5:32 am ET1min read
Baillie Gifford's latest 13F filing shows the firm added 18 stocks, including Tempus AI, Dollar General, and FTAI Aviation. It increased stakes in 55 stocks, notably Reddit and AppLovin. The firm completely exited 20 holdings, including BeOne Medicines and Elastic. Baillie Gifford also reduced positions in 175 stocks, most notably Shopify and Workday.
Baillie Gifford's latest 13F filing reveals a substantial shift in its investment portfolio, with notable additions, increases, and exits. The firm added 18 new stocks, including Tempus AI, Dollar General, and FTAI Aviation, while increasing stakes in 55 stocks, such as Reddit and AppLovin. Additionally, Baillie Gifford completely exited 20 holdings, including BeOne Medicines and Elastic, and reduced positions in 175 stocks, most notably Shopify and Workday.Among the notable additions, FTAI Aviation (NASDAQ: FTAI) stands out. The financial services provider has seen a significant increase in institutional ownership, with analysts setting new price targets and a consensus rating of "Buy" [1]. The company's recent earnings report showed strong performance, with earnings per share (EPS) of $1.57, beating analysts' estimates by $0.24. Additionally, FTAI Aviation announced a quarterly dividend of $0.30 per share, with an annualized yield of 0.9%.
Another key addition is Tempus AI, a technology company focused on artificial intelligence and machine learning in healthcare. The company has seen increasing interest from investors due to its innovative approach to data analytics and its potential to disrupt the healthcare industry.
Baillie Gifford also increased its stake in AppLovin Corporation (NASDAQ: APP), a mobile advertising company. The firm's latest earnings report showed strong revenue growth of 40.3% compared to the same quarter last year, with EPS of $1.67, beating analysts' estimates by $0.22. The company's market capitalization stands at $133.67 billion, with a price-to-earnings ratio of 71.30 and a beta of 2.43.
On the other hand, Baillie Gifford completely exited BeOne Medicines, a biotechnology company focused on developing innovative cancer treatments. The company's stock has been volatile, with a 12-month low of $2.50 and a 12-month high of $12.50. The firm also reduced its position in Shopify (NYSE: SHOP), an e-commerce platform, and Workday (NASDAQ: WDAY), a cloud-based financial management software company.
The portfolio adjustments reflect Baillie Gifford's strategy of focusing on companies with strong growth prospects and innovative business models. The firm's latest 13F filing provides valuable insights into its investment thesis and its approach to portfolio management.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-ing-groep-nv-buys-new-position-in-ftai-aviation-ltd-nasdaqftai-2025-08-06/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet